https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2823%2900122-6/fulltext
0
0
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet
4/13/23 at 10:31pm
Organization
The Lancet
Authors
Details
60 words
Summarize
general Medical Procedures Infectious Diseases mRNA vaccine booster dose The Lancet Participants mRNA booster vaccine dose importan
Participants who received a bivalent mRNA booster vaccine dose had lower rates of hospitalisation due to COVID-19 than participants who did not receive a bivalent booster vaccination, for up to 120 days after vaccination. These findings highlight the importan…
Create an account or login to join the discussion